Register
Login:
Share:
Email Facebook Twitter

Share Views: HUM CEO updates on Yanfolila and Dugbe Gold Projects. Watch here

Share Views Ep. 19
HUM CEO updates on Yanfolila and Dugbe Gold Projects.


Summit Ther Share Price (SUMM)



Share Price Information for Summit Ther (SUMM)


Share Price: 169.00Bid: 165.00Ask: 173.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 8.00Spread as %: 4.85%Open: 170.00High: 170.00Low: 169.00Yesterday’s Close: 169.00

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
169.00

Share Price SpacerBid
165.00

Share Price SpacerAsk
173.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
20,753

Share Price SpacerOpen
170.00

Share Price SpacerHigh
170.00

Share Price SpacerLow
169.00

Share Price SpacerClose
169.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 61.82m £104.47m 2,000

52 Week High 260.00 52 Week High Date 4-OCT-2016
52 Week Low 82.50 52 Week Low Date 4-MAR-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
8 4,213 16,540 -5.828 -29.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

02-Dec-16
15:55:04
172.44
5,000
Buy* 
165.00
173.00
8,622
Trade Type:
Ordinary

02-Dec-16
14:03:09
172.22
1,000
Buy* 
165.00
173.00
1,722
Trade Type:
Ordinary

02-Dec-16
13:49:04
166.62
2,000
Sell* 
165.00
175.00
3,332
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
18-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
David Wurzer held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 David Wurzer
2.33USD7,5007500
17-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
Valerie Andrews held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Valerie Andrews
2.3USD10,50010500
16-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
2.34USD4,25014442
View more Summit Ther directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Fri 19:12pomanderRE: Award for Summit this evening !!169.00No Opinion
Hopefully they can translate to deals.
Thu 08:40gmccRE: Award for Summit this evening !!176.00No Opinion
Thanks Chris for sharing -well done Summit team helps company profile on C-Diff !

https://twitter.com/hashtag/ScripAwards?src=hash
Wed 22:22ChrisatrdgAward for Summit this evening !!178.50Strong Buy
They won !!!!!
Scrip ‏@PharmaScrip 51s52 seconds ago
.@Summitplc’s Phase II CoDIFy study win #ScripAwards 2016 QuintilesIMS' Clinical Advance of the Year Award
0 replies 0 retweets 0 likes
Reply Retweet
Like
More
Wed 17:20gmccDMD (PhaseOut DMD)178.50No Opinion
FYI : DMD (PhaseOut DMD)

Making some progress , few more sites recruiting Last updated: November 29, 2016

https://clinicaltrials.gov/show/NCT02858362

https://clinicaltrials.gov/ct2/archive/NCT02858362

Good luck everyone !
Tue 09:22PhookaRE: Jim Mellon on Brexit & Ĩ interview176.00No Opinion
You have to click the "Share Views: JIM MELLON. The billionaire private investor interviewed for lse.co.uk Watch here" button at the top of the page.
Tue 09:20PhookaJim Mellon on Brexit & Ĩ interview176.00Hold
Good interview with Jim Mellon re Brexit, the Italians and the rest of Europe. Gets interesting from about 14 mins till the end.
http://www.lse.co.uk/SharePrice.asp?SharePrice=summ&goButton=Go

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Summit Ther (SUMM) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.